Lineage Cell Therapeutics (LCTX) Capital Leases (2015 - 2026)
Lineage Cell Therapeutics (LCTX) recorded Capital Leases of $15,000 in Q2 2026, down 68.8% from $48,000 a year earlier and down 31.8% from the prior quarter.
Powered by 
Analysis
Lineage Cell Therapeutics (LCTX) Capital Leases (2015 - 2026) Analysis & Trends
At the end of FY2025, Lineage Cell Therapeutics reported Capital Leases of $32,000, down 52.2% from FY2024.
- Annual Capital Leases has a five-year compound annual growth rate of 4.2% (FY2020 to FY2025).
- Across earlier years, Capital Leases came in at $67,000 in FY2024 (-26.4%), $91,000 in FY2023 (+8.3%), $84,000 in FY2022 (+180.0%) and $30,000 in FY2021 (+15.4%).
- The Q2 2026 figure is the lowest quarterly Capital Leases since Q3 2021.
- On a year-over-year basis, Capital Leases has declined for ten consecutive quarters, with an average decline of 42.1% over the last eight quarters.
- Peak year-over-year performance for Capital Leases in the last five years was growth of 506.3% in Q3 2023, against a decline of 68.8% in Q2 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $22,000 (Q1 2026), $32,000 (Q4 2025) and $40,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn |
| 10 | Lineage Cell Therapeutics | 247.85 Mn | 46.25 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 15,000.00 |
| Mar 31, 2026 | 22,000.00 |
| Dec 31, 2025 | 32,000.00 |
| Sep 30, 2025 | 40,000.00 |
| Jun 30, 2025 | 48,000.00 |
| Mar 31, 2025 | 51,000.00 |
| Dec 31, 2024 | 67,000.00 |
| Sep 30, 2024 | 80,000.00 |
| Jun 30, 2024 | 68,000.00 |
| Mar 31, 2024 | 79,000.00 |
| Dec 31, 2023 | 91,000.00 |
| Sep 30, 2023 | 97,000.00 |
| Jun 30, 2023 | 113,000.00 |
| Mar 31, 2023 | 133,000.00 |
| Dec 31, 2022 | 84,000.00 |
| Sep 30, 2022 | 16,000.00 |
| Jun 30, 2022 | 19,000.00 |
| Mar 31, 2022 | 26,000.00 |
| Dec 31, 2021 | 30,000.00 |
| Sep 30, 2021 | 12,000.00 |
API Access
Lineage Cell Therapeutics Capital Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-leases&ticker=LCTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-leases", "ticker": "LCTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-leases&ticker=LCTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();